122 related articles for article (PubMed ID: 12484035)
1. [A study of the oncolytic effect of a newly designed CDDP system on an experimental animal model with carcinomatous ascites].
Shindoh T; Matsuura N; Sugitachi A; Saitoh K
Gan To Kagaku Ryoho; 2002 Nov; 29(12):2195-8. PubMed ID: 12484035
[TBL] [Abstract][Full Text] [Related]
2. [A newly designed system, "FC-UV-CDDP", and a study of its oncolytic effect].
Shindoh T; Matsuura N; Sugitachi A; Saitoh K
Gan To Kagaku Ryoho; 2001 Oct; 28(11):1534-7. PubMed ID: 11707973
[TBL] [Abstract][Full Text] [Related]
3. [Injectable drug carriers with sustained release of cis-platinum].
Sugitachi A; Kashiwaba M; Takagane A; Asahi H; Saitoh K; Yoshida Y; Shindoh T; Matsuura N
Gan To Kagaku Ryoho; 2003 Oct; 30(11):1851-4. PubMed ID: 14619537
[TBL] [Abstract][Full Text] [Related]
4. [A loco-regional cancer chemotherapy, using a fibrin clot as a drug carrier--the oncolytic effects and putative mechanisms].
Sugitachi A; Kohayakawa K; Kawahara T; Shindo T
Gan To Kagaku Ryoho; 1991 Aug; 18(11):1817-21. PubMed ID: 1877823
[TBL] [Abstract][Full Text] [Related]
5. [A novel sustained release system for aqueous cis-platinum].
Sugitachi A; Kashiwaba M; Takagane A; Asahi H; Saitoh K; Takahashi M; Nakajima H; Shindoh T; Matsuura N
Gan To Kagaku Ryoho; 2002 Nov; 29(12):2191-4. PubMed ID: 12484034
[TBL] [Abstract][Full Text] [Related]
6. [Novel dosage forms with a sustained release of aqueous cis-platinum].
Sugitachi A; Kashiwaba M; Takagane A; Asahi H; Saito K; Yoshida Y; Shindo T; Matsuura N
Gan To Kagaku Ryoho; 2004 Oct; 31(11):1758-60. PubMed ID: 15553706
[TBL] [Abstract][Full Text] [Related]
7. [Loco-regional cancer chemotherapy with a new drug delivery system, "anticancer drug-fibrin clot"].
Sugitachi A; Takatsuka Y; Numata N; Kawahara T; Hirata M; Kido T; Sakamoto I
Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2814-7. PubMed ID: 2782891
[TBL] [Abstract][Full Text] [Related]
8. A newly designed anticancer tumor immunity drug delivery system.
Sugitachi A; Shindo T; Matsuda Y; Sakamoto I
ASAIO Trans; 1991; 37(3):M177-8. PubMed ID: 1751099
[TBL] [Abstract][Full Text] [Related]
9. [A novel Cisplatin delivery system for malignant ascites-bearing mice-a basic experimentation].
Itabashi T; Sugitachi A; Kimura Y; Ikeda M; Kumagai M; Matsuo T; Fujii H; Nishizuka S; Otsuka K; Koeda K; Sasaki A; Wakabayashi G
Gan To Kagaku Ryoho; 2011 Nov; 38(12):2081-3. PubMed ID: 22202290
[TBL] [Abstract][Full Text] [Related]
10. [A novel formulation of cisplatin (CDDP)].
Sugitachi A; Kimura Y; Itabashi T; Noda H; Ishida K; Nishizuka S; Otsuka K; Kashiwaba M; Nitta H; Koeda K; Mizuno M; Sasaki A; Ikeda K; Takamori Y; Wakabayashi G
Gan To Kagaku Ryoho; 2009 Nov; 36(12):2294-6. PubMed ID: 20037400
[TBL] [Abstract][Full Text] [Related]
11. Experimental and clinical evaluation of cisplatin-containing microspheres as intraperitoneal chemotherapy for ovarian cancer.
Sugiyama T; Kumagai S; Nishida T; Ushijima K; Matsuo T; Yakushiji M; Hyon SH; Ikada Y
Anticancer Res; 1998; 18(4B):2837-42. PubMed ID: 9713471
[TBL] [Abstract][Full Text] [Related]
12. [Anticancer efficacy with cisplatin delivery systems].
Sugitachi A; Kimura Y; Itabashi T; Ikeda M; Ishida K; Noda H; Matsuo T; Nishizuka S; Otsuka K; Koeda K; Sato A; Takahashi T; Wakabayashi G
Gan To Kagaku Ryoho; 2010 Nov; 37(12):2274-6. PubMed ID: 21224545
[TBL] [Abstract][Full Text] [Related]
13. Amifostine increases cure rate of cisplatin on ascites hepatoma 22 via selectively protecting renal thioredoxin reductase.
Zhang J; Wang X; Lu H
Cancer Lett; 2008 Feb; 260(1-2):127-36. PubMed ID: 18039557
[TBL] [Abstract][Full Text] [Related]
14. [A novel fibrin clot with a sustained release of cis-platinum (CDDP)].
Sugitachi A; Takagane A; Terashima M; Kashiwaba M; Shimada H; Asahi H; Saitoh K
Gan To Kagaku Ryoho; 2000 Oct; 27(12):1861-4. PubMed ID: 11086431
[TBL] [Abstract][Full Text] [Related]
15. [Repeated intraperitoneal injection of low-dose CDDP for gastric cancer with ascites owing to peritonitis carcinomatosa].
Nakagawa M; Ninomiya M; Fujita I; Matsubara M; Okamoto Y; Kawamoto H; Araki Y; Inoue J; Sasaki H; Takakura N
Gan To Kagaku Ryoho; 2002 Nov; 29(12):2346-9. PubMed ID: 12484071
[TBL] [Abstract][Full Text] [Related]
16. Nanospheres-incorporated implantable hydrogel as a trans-tissue drug delivery system.
Ding D; Zhu Z; Li R; Li X; Wu W; Jiang X; Liu B
ACS Nano; 2011 Apr; 5(4):2520-34. PubMed ID: 21428432
[TBL] [Abstract][Full Text] [Related]
17. The use of biotinylated-EGF-modified gelatin nanoparticle carrier to enhance cisplatin accumulation in cancerous lungs via inhalation.
Tseng CL; Su WY; Yen KC; Yang KC; Lin FH
Biomaterials; 2009 Jul; 30(20):3476-85. PubMed ID: 19345990
[TBL] [Abstract][Full Text] [Related]
18. [Chitin/cisplatin--an adhesive anticancer drug].
Sugitachi A; Otsuka K; Itabashi T; Chiba T; Kimura Y; Sasaki A; Ikeda K; Uesugi N; Takamori Y; Kurozumi S; Mori T; Wakabayashi G
Gan To Kagaku Ryoho; 2008 Nov; 35(12):2021-3. PubMed ID: 19106510
[TBL] [Abstract][Full Text] [Related]
19. Antitumor efficacy of cisplatin-loaded glycol chitosan nanoparticles in tumor-bearing mice.
Kim JH; Kim YS; Park K; Lee S; Nam HY; Min KH; Jo HG; Park JH; Choi K; Jeong SY; Park RW; Kim IS; Kim K; Kwon IC
J Control Release; 2008 Apr; 127(1):41-9. PubMed ID: 18234388
[TBL] [Abstract][Full Text] [Related]
20. A new chemosensitivity assay for ascites tumor cells using a thermoreversible gelation polymer as a culture medium and the observed clinical responses.
Isogai A; Nagaya M; Matsuoka H; Watanabe T; Tsukikawa S; Kubota S
Eur Surg Res; 2007; 39(1):41-50. PubMed ID: 17213726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
